Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Phase I Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of HMPL-760 in Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

NCT05190068 is registered in ClinicalTrials.gov with Hutchmed as lead sponsor.

NCT NCT05190068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05190068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Phase I Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of HMPL-760 in Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Lead sponsor
Hutchmed
Phase
Phase 1
Overall status
Completed
Start date
January 4, 2022
Completion date
January 27, 2025
Enrollment
89 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell non-hodgkin's lymphoma